1. Home
  2. APYX vs BDTX Comparison

APYX vs BDTX Comparison

Compare APYX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$3.51

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.49

Market Cap

148.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
BDTX
Founded
1982
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
143.2M
148.1M
IPO Year
1987
2020

Fundamental Metrics

Financial Performance
Metric
APYX
BDTX
Price
$3.51
$2.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$7.00
$10.60
AVG Volume (30 Days)
57.1K
1.6M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.38
Revenue
$47,902,000.00
$70,000,000.00
Revenue This Year
$8.41
N/A
Revenue Next Year
$7.01
N/A
P/E Ratio
N/A
$6.43
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$1.20
52 Week High
$4.44
$4.94

Technical Indicators

Market Signals
Indicator
APYX
BDTX
Relative Strength Index (RSI) 42.53 33.50
Support Level $3.35 $2.52
Resistance Level $3.65 $2.69
Average True Range (ATR) 0.16 0.12
MACD -0.04 0.03
Stochastic Oscillator 25.00 17.44

Price Performance

Historical Comparison
APYX
BDTX

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: